Miist, founded by a 25-year-old, wants people to vape their way out of smoking addiction and migraines

February 5, 2025

, By admin

Share via:

As a university student, Dalton Signor was troubled by how many people around him smoked or vaped, including his grandmother and 14-year-old sister.

Signor (pictured center) felt that existing smoking cessation medicines, whether patches, gums, or lozenges, are not very effective because they take too long to start working. “They take about 30 minutes to provide relief, but the average person relapses in 11 minutes,” he told TechCrunch.

So, three years ago, he set out to develop a withdrawal-inhibitor inhaler because delivering…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Previous News

Bhavish Aggarwal to invest Rs 2,000 crore in AI startup Krutrim, unveils open-source models

Next News

Cashfree Payments Bags $53 Mn From KRAFTON

Hi! This is Admin.

Popular

More Like this

Miist, founded by a 25-year-old, wants people to vape their way out of smoking addiction and migraines

February 5, 2025

, By admin

As a university student, Dalton Signor was troubled by how many people around him smoked or vaped, including his grandmother and 14-year-old sister.

Signor (pictured center) felt that existing smoking cessation medicines, whether patches, gums, or lozenges, are not very effective because they take too long to start working. “They take about 30 minutes to provide relief, but the average person relapses in 11 minutes,” he told TechCrunch.

So, three years ago, he set out to develop a withdrawal-inhibitor inhaler because delivering…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

Previous News

Bhavish Aggarwal to invest Rs 2,000 crore in AI startup Krutrim, unveils open-source models

Next News

Cashfree Payments Bags $53 Mn From KRAFTON

Hi! This is Admin.

More like this

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!